Mehra Anand — SEC Form 4 filings
SEC reporting owner CIK 1590102. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-09 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 666,666 shares, $1,499,998 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: purchase of 666,666 shares @ $2.25 ($1,499,998) in Aclaris Therapeutics, Inc., filed 2024-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | Director | 5 | 1 leg · 666,666 sh · $1,499,998 | — | 12 |
| Merus N.V. (MRUS) | Director | 3 | — | — | 12 |
Form 4 filings — Mehra Anand
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 11,580 · Grant/award (A): 42,350 (derivative) @ $0 · Grant/award (A): 10,987 (derivative) @ $0 · Option exercise (M): 11,580 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Merus N.V. (MRUS) | Disposition to issuer (D): 13,193 (derivative) @ $0 · Disposition to issuer (D): 8,844 (derivative) @ $0 · Disposition to issuer (D): 14,414 (derivative) @ $0 · Disposition to issuer (D): 16,604 (derivative) @ $0 · Disposition to issuer (D): 6,120 (derivative) @ $0 · Disposition to issuer (D): 8,631 (derivative) @ $0 · +4 more | EDGAR |
| 2025-06-09 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 4,793 · Grant/award (A): 42,350 (derivative) @ $0 · Grant/award (A): 11,580 (derivative) @ $0 · Option exercise (M): 4,793 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Merus N.V. (MRUS) | Grant/award (A): 13,193 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Purchase (P): 666,666 @ $2.25 | EDGAR |
| 2024-06-10 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 15,750 (derivative) @ $0 · Grant/award (A): 4,793 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 4,660 · Option exercise (M): 4,660 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | Merus N.V. (MRUS) | Grant/award (A): 8,844 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1590102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →